Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy

Obstetrics and Gynecology

Volumn 89, Issue 1, 1997, Pages 97-103

  Akkad, Andrea A ^b   Halligan, Aidan W F ^b   Abrams, Keith ^b   Al Azzawi, Farook ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS ESTRIOL PLUS ESTRONE; ESTRIOL; ESTROGEN; ESTRONE; HORMONIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG MIXTURE; DRUG RESPONSE; ESTROGEN THERAPY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MASTALGIA; NAUSEA; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TABLET; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031012117     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)84258-5     Document Type: Article

References (21)

1. Bush TL, Miller VG. Effects of pharmacologic agents used during menopause: Impact on lipids and lipoproteins. In: Mishell DR Jr, ed. Menopause: Physiology and pharmacology. Chicago: Year Book Medical Publishers, 1987:187-208.
2. Lip YH, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994;8:491-4.
3. Luotola H. Blood pressure and haemodynamics in postmenopausal women during estradiol-17β substitution. Ann Clin Res 1983;15(suppl 38):9.
4. Wren BG, Routlage DA. Blood pressure changes. Œstrogens in climacteric women. Med J Aust 1981;2:528-31.
5. Lobo RA. Estrogen replacement therapy and hypertension. J Postgrad Med 1987;33:48-55.
6. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988;259:225-8.
7. Harshfield GA, Pickering TG, Laragh JH. A validation study of the Del Mar Avionics ambulatory blood pressure system. Ambulatory Electrocardiogr 1979;4:7-12.
8. Devereaux RB, Pickering TG. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. J Hypertens 1991;9(8 suppl):34-8.
9. Verdecchia P, Schillaci G, Gatteschi C, Zampi I, Battistelli M, Bartoccini C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993;88:986-92.
10. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991;9:573-4.
11. Conway J, Coates A. Value of ABP monitoring in clinical pharmacology. J Hypertens 1989;7(3 suppl):29-32.
12. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 1990;81:700-2.
13. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Sacchi N, Batistelli M, et al. Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension. Dippers and peakers. Am J Hypertens 1995;8:193-6.
14. Devereaux R, Pickering T, Harshfield G, Kleinert H, Denby L, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress. Circulation 1983;68:470-6.
15. Hassager C, Riis BJ, Strøm V, Guyenne TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 1987;76:753-8.
16. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986;314:1615-6.
17. Wren BG. Hypertension and thrombosis with postmenopausal estrogen therapy. In: Studd JJW, Whitehead M, eds. The menopause. London: Blackwell Scientific Publications, 1988:181-9.
18. Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen - a calcium antagonist effect? Lancet 1993;341:1264-5.
19. Mügge A, Riedel M, Barton M, Kuhn M, Lichteln PR. Endothelium independent relaxation of human coronary arteries by 17β-œstradiol in vitro. Cardiovasc Res 1993;27:1939-42.
20. Shionori H, Eggena P, Barrett JD. An increase in high-molecular-weight renin-substrate associated with estrogenic hypertension. Biochem Med 1983;29:14-22.
21. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-10.